Research shows that severe hearing loss in childhood cancer survivors is associated with neurocognitive deficits independent of type of therapy. Read more: https://www.eurekalert.org/pub_releases/2020-07/sjcr-jbp072820.php
"The experimental drug, known as 9-ING-4, targets a specific protein that seems to be active in many different types of cancer." Read more: https://turnto10.com/features/health-landing-page/new-drug-may-provide-hope-for-children-with-untreatable-cancers
After discovering how a specific gene fuels a deadly form of children’s brain tumour, University of Manitoba researchers have successfully decreased this cancer in mice. Read more: https://news.umanitoba.ca/um-researchers-find-new-targets-for-deadly-childrens-brain-tumour/
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Read more: https://www.eurekalert.org/pub_releases/2020-07/uoth-fha071620.php#
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to "kinder" treatments for children with bone cancer, and save lives. Read more: https://medicalxpress.com/news/2020-07-scientists-devastating-childhood-cancer.html
As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD. Read more: https://www.healio.com/news/hematology-oncology/20200709/despite-treatment-advances-much-to-improve-upon-in-highrisk-neuroblastoma
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress. Read more: https://www.eurekalert.org/pub_releases/2020-07/bch-mfb070820.php
Adding rituximab (Rituxan, Truxima) to chemotherapy may be a new standard for treating children and young adults newly diagnosed with aggressive B-cell lymphoma, according to findings from a randomized, international, phase 3 trial. Read more: https://www.ajmc.com/newsroom/rituximab-regimen-improves-survival-in-children-with-aggressive-bcell-lymphoma